Fang, S., Jin, G., Yan, M., Song, Y., Zhao, S., Zhang, C., Shao, Y., Zhao, K., Liu, M., Wang, Z., Jia, X., Guo, Q., Guo, M., Wang, M., Guo, Z., Dong, Z. (2026). PHGDH phosphorylation mediated by WNK1 serves as a dual marker of metabolic vulnerability and responsiveness to oxaliplatin treatment. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2525213123